Fisher & Paykel Healthcare Corporation Limited Stock OTC Markets
Equities
FSPKF
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.43 USD | +1.80% | +1.80% | +16.44% |
Sales 2024 | 1.74B 1.07B | Sales 2025 * | 1.99B 1.22B | Capitalization | 16.15B 9.9B |
---|---|---|---|---|---|
Net income 2024 | 133M 81.52M | Net income 2025 * | 347M 213M | EV / Sales 2024 | 8.59 x |
Net Debt 2024 * | 174M 106M | Net Debt 2025 * | 238M 146M | EV / Sales 2025 * | 8.26 x |
P/E ratio 2024 |
113
x | P/E ratio 2025 * |
47.9
x | Employees | 6,420 |
Yield 2024 * |
1.42% | Yield 2025 * |
1.64% | Free-Float | 91.12% |
Latest transcript on Fisher & Paykel Healthcare Corporation Limited
1 day | +1.80% | ||
1 week | +1.80% | ||
Current month | +1.80% | ||
1 month | +1.80% | ||
3 months | +12.53% | ||
6 months | +30.92% | ||
Current year | +16.44% |
Managers | Title | Age | Since |
---|---|---|---|
Lewis Gradon
CEO | Chief Executive Officer | 63 | 84-12-31 |
Lyndal York
DFI | Director of Finance/CFO | - | 19-02-28 |
Nicholas Fourie
CTO | Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 66 | 90-04-30 |
Scott St. John
CHM | Chairman | - | 15-09-30 |
Lewis Gradon
CEO | Chief Executive Officer | 63 | 84-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.10% | 40.74B | |
+19.92% | 31.6B | |
+16.46% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- FPH Stock
- FSPKF Stock